Cite
HARVARD Citation
Guerbau, L. et al. (2017). Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab. Inflammatory bowel diseases. 23 (10), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guerbau, L. et al. (2017). Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab. Inflammatory bowel diseases. 23 (10), p. . [Online].